Acella Pharmaceuticals NP Thyroid Tablets Recall
Acella Pharmaceuticals has announced its recent recall on their NP thyroid tablets. The recall includes one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets [levothyroxine (T4) and liothyronine (T3)].
The recall has been issued after testing confirmed that the products were sub potent. According to reports, the product contains as low as 87% of the labeled amount of levothyroxine (T4).
Have you purchased Acella Pharmaceuticals/ NP Thyroid Tablets? Have you experienced any side effects? Tell us more about it.
Consumers who’ve been on treatment for hypothyroidism (underactive thyroid) and took sub potent NP Thyroid may suffer some side effects. The following are the signs and symptoms connected to the sub potent tablets:
- increased sensitivity to cold
- dry skin
- puffy face
- hair loss
- slow heart rate
- swelling of the thyroid gland
- unexplained weight gain or difficulty losing weight
As of this time, Acella Pharmaceuticals has received four reports of consumers suffering symptoms after taking NP thyroid tablets.
What You Need To Do
For those patients who are taking the recalled products as part of their treatment, you are advised not to immediately stop taking the medication. It’s important to first contact your healthcare provider for proper guidance and replacement prescription.
Meanwhile, for consumers who may have other concerns about the recall, you can contact (888) 280-2044, Monday through Friday from 8:00 am to 5:00 pm (ET) or email Acella Pharmaceuticals at email@example.com.
Editor’s note on the Acella Pharmaceuticals NP Thyroid Tablets Recall:
This piece is to inform you about the recent Acella Pharmaceuticals NP Thyroid Tablets Recall
We’d be happy to help you take a step in the right direction, fight this issue, and better enable you to join in on any potential consumer class action. If interested, please send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter or Facebook, or even connect with us directly on our website! We look forward to hearing from you all.
Similarly, please check out our current list of Class Actions and Class Action Investigations, here.
Interested in articles like these? Become a subscriber below!